Dr. Ashok Narasimhan

Ashok obtained his Master’s in genetics from India and PhD from the University of Alberta. His PhD thesis work was focused on exploring the role of regulatory molecules (small non-coding RNAs and splice variants) in cancer associated muscle and fat wasting, also known as cachexia. In his first postdoc at Indiana University, he focused on conducting preclinical drug screens, testing the effects of chemotherapy on muscle, and characterizing the functional significance and mechanism of microRNAs in muscle wasting. He joined Rossi lab in June 2021 where his primary objective is to understand the role of microRNAs in FAPs dysregulation in cancer cachexia.

Ashok obtained his Master’s in genetics from India and PhD from the University of
Alberta. His PhD thesis work was focused on exploring the role of regulatory
molecules (small non-coding RNAs and splice variants) in cancer associated muscle
and fat wasting, also known as cachexia. In his first postdoc at Indiana University,
he focused on conducting preclinical drug screens, testing the effects of
chemotherapy on muscle, and characterizing the functional significance and
mechanism of microRNAs in muscle wasting. He joined Rossi lab in June 2021 where
his primary objective is to understand the role of microRNAs in FAPs dysregulation
in cancer cachexia


Ashok obtained his Master’s in genetics from India and PhD from the University of
Alberta. His PhD thesis work was focused on exploring the role of regulatory
molecules (small non-coding RNAs and splice variants) in cancer associated muscle
and fat wasting, also known as cachexia. In his first postdoc at Indiana University,
he focused on conducting preclinical drug screens, testing the effects of
chemotherapy on muscle, and characterizing the functional significance and
mechanism of microRNAs in muscle wasting. He joined Rossi lab in June 2021 where
his primary objective is to understand the role of microRNAs in FAPs dysregulation
in cancer cachexia.

---